Q3 2025 Earnings Call Transcript October 29, 2025 Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is ...

Fanapt® Q3 2025 net product sales increased by 31% to $31.2 million compared to Q3 2024 BysantiTM (milsaperidone) NDA for bipolar I disorder and schizophrenia ...

Q3 2025 Management View CEO Mihael Polymeropoulos reported "strong commercial execution with total net product sales reaching ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the third quarter ...

Learn more about whether AbbVie Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, ...

LEO Pharma A/S, a global leader in medical dermatology, is advancing the understanding of skin disease and its impact on ...

Approximately 43% of patients experienced at least 1 flare during follow-up, most occurring within the first year of diagnosis. Finnish patients with confirmed generalized pustular psoriasis (GPP) ...

1 Department of Pediatric Nephrology and Rheumatism and Immunology, Children’s Hospital Affiliated to Shandong University, Jinan, Shandong, China 2 Department of Pediatric Nephrology and Rheumatism ...

LEO Pharma, a global leader in medical dermatology, has successfully closed the deal for Spevigo® with Boehringer Ingelheim, as announced on July 14, 2025, following approval from all relevant ...

Adding Spevigo ® is a significant step forward in LEO Pharma’s focused growth strategy, to accelerate and expand patients’ access to treatments for medical dermatological conditions, including ...

Over 60 million people worldwide are affected by psoriasis, a chronic inflammatory skin disorder that causes red, scaly patches and persistent itching. A new study has found that following a ...

A while back, I published the Design Idea (DI) “Simple PWM interface can program regulators for Vout < Vsense.” It showed some simple circuits for PWM programming of standard bucking-type regulator ...